3671 - 3680 of 7915 Results
Title
Year
-
OPENTitle: Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 642End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28360Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/167040/1/mds28360_am.pdfCitation Count: 54
- Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?2020OPENTitle: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?Journal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00076-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00076-yCitation Count: 2
-
OPENTitle: Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activityJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 477Issue #: 22Start Page: 4397End Page: 4423Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200458Best OA location URL: https://portlandpress.com/biochemj/article-pdf/477/22/4397/898287/bcj-2020-0458.pdfCitation Count: 57
- Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary2020OPENTitle: Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and CommentaryJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 7End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-020-00220-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-020-00220-5.pdfCitation Count: 36
-
OPENTitle: Lack of evidence for association of UQCRC1 with Parkinson's disease in EuropeansJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 101Issue #:Start Page: 297.e1End Page: 297.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.030Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938960Citation Count: 7
- Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset2020RESTRICTEDTitle: Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmosetJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 182Issue #:Start Page: 108386End Page: 108386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2020.108386Citation Count: 12
-
RESTRICTEDTitle: The Emerging Role of the Lysosome in Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2399End Page: 2399Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112399Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2399/pdf?version=1604479812Citation Count: 74
- 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases2020OPENTitle: 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseasesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3477End Page: 3494Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa276Best OA location URL: https://academic.oup.com/brain/article-pdf/143/11/3477/36134848/awaa276.pdfCitation Count: 107
-
RESTRICTEDTitle: A validation of a self-administered screening test for Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 418Issue #:Start Page: 117116End Page: 117116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117116Citation Count: 1
- Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias2020RESTRICTEDTitle: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 951End Page: 962Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8Best OA location URL: http://manuscript.elsevier.com/S1474442220303148/pdf/S1474442220303148.pdfCitation Count: 283